downloadDownload

Small molecule inhibitors of hyperphosphorylated tau aggregation in Alzheimer's disease: lead optimization, and proof of concept in a rodent model

assignment_turned_inproject15 May 2022(Started)-30 Apr 2027(Ending)On going (M44)

Funder: National Institutes of HealthProject code: 1K08AG071985-01A1

Funded under: NATIONAL INSTITUTE ON AGING Funder Contribution: 164,221 USD

Small molecule inhibitors of hyperphosphorylated tau aggregation in Alzheimer's disease: lead optimization, and proof of concept in a rodent model

- Summary
- DMPs

Partners

PURDUE UNIVERSITY , PURDUE UNIVERSITY

Data Management Plans

Start a new DMP in Argos

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=nih_________::3b764285b548e6d1c62ca88439a49654&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Small molecule inhibitors of hyperphosphorylated tau aggregation in Alzheimer's disease: lead optimization, and proof of concept in a rodent model

Small molecule inhibitors of hyperphosphorylated tau aggregation in Alzheimer's disease: lead optimization, and proof of concept in a rodent model

Loading